Atraverse Medical, a San Diego, CA-based medical device company, has secured $12.5 million in seed funding. This round of financing saw participation from physicians, esteemed venture investors, and successful medtech entrepreneurs.
The newly raised funds will be utilized to expand the company’s research and development efforts and support early commercialization initiatives. Atraverse Medical is dedicated to advancing its innovative medical devices to improve patient outcomes and streamline medical procedures.
Led by CEO John Slump, Atraverse Medical recently announced that it has received FDA clearance for its HOTWIRE™ radiofrequency (RF) guidewire. This groundbreaking device, invented by Atraverse Co-Founders Dr. Steven Mickelsen and Eric Sauter, enables zero exchange left-heart access while also functioning as a rail for catheter-based therapy systems. This FDA clearance is a significant milestone for the company, paving the way for the commercialization of its left-heart access technology.
“We are thrilled to have received FDA clearance for our HOTWIRE™ RF guidewire, which represents a major advancement in left-heart access procedures,” said CEO John Slump. “This funding will allow us to further our R&D efforts and begin early commercialization, bringing this innovative technology to healthcare providers and patients.”
